🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
21.01
+0.36 (1.74%)
At close: Nov 18, 2026, 4:00 PM EST
21.49
+0.48 (2.28%)
After-hours: Nov 18, 2026, 7:45 PM EST

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $307.00K in the quarter ending September 30, 2026, a decrease of -96.83%. This brings the company's total for the last twelve months to $146.64M, up 163.27% year-over-year. In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth. That makes Beam Therapeutics the 19,816th largest company in the world by revenue and 3,054th in the United States.

Revenue (ttm)
$146.64M
Revenue Growth
+163.27%
P/S Ratio
14.28
Revenue / Employee
$263,275
Employees
557
Market Cap
2.09B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018---